Abstract:AIM:To analyze the quantitative differences between hepatitis B virus markers (HBV M) and HBV DNA in population with high-level or low-level HBsAg, and to reveal the characteristics of HBV DNA and HBV M in population with low-level HBsAg. METHODS:A total of 264 chronic HBV-infected patients were enrolled in our study, and were divided into low-level HBsAg group (147 cases) and high-level HBsAg group (117 cases) based on the HBsAg level or were divided into immune tolerance stage, immune clearance stage and non-active stage based on the natural history. Real-time PCR and microparticle enzyme immunoassay (MEIA) were used to determine the content of HBV DNA and HBV M in serum samples of high-level and low-level HBsAg patients, respectively, then the quantitative results were compared. RESULTS:There were statistically significant differences between HBV DNA and HBV M (anti-HBs, HBeAg and anti-HBe) of low-level HBsAg patients in immune tolerance stage (7 cases) and immune clearance stage(4 cases) (t=2.531-9.181, P<0.01-0.05). HBV DNA lower than 10(5) copies/L was found in 94.1% (128/136) of serum samples in non-active stage, and the detection rates of direct PCR and enriching PCR were 10.3% (14/136) and 10.3% (47/136) in low-level HBsAg group, respectively, and there were no correlations between HBV DNA and each of HBV M (P>0.05). In high-level HBsAg group, HBV DNA was positively correlated with HBeAg and anti-HBe in 25 cases of immune tolerance stage (r=0.744-0.772, t(r)=3.858-4.207, P<0.01), and was only negatively correlated with anti-HBs in 46 cases of immune clearance stage and 46 cases of non-active stage (r=-0.693 - -0.598, t(r)=-4.616 - -3.936, P<0.01-0.05). CONCLUSION:Population with low-level HBsAg have specific serological characteristics, which may be correlated with organic immune tolerance and individualized immune responses.

Analysis of Correlation Between the PreS1-Ag and HBV-DNA of the Patients with Hepatitis B

Relativity among PreS1-antigen,HBV Markers and HBV-DNA

Correlation between pre-S1 antigen and HBV-DNA, HBeAg in hepatitis B patients

[Relationship between the quantitative results of HBV DNA and HBV markers (HBV M) in population with low-level HBsAg].

Analysis of the Joint Inspection of PreS1 Antigen of Hepatitis B and Hepatitis B Serum Markers

Characteristics of patients with concurrent HBsAg and HBsAb in serum

Value of Pre S1 Protein in Diagnosis of HBV Infection

Relationship Between Serological Markers,Pre-S1Protein and HBV-DNA in Patients with Hepatitis B

Study on Associations Between HBV DNA and Pre-S1 Antigen and Serum Markers of HBV

Evaluation on the correlation between HBV-DNA and serum HBV-LP of patients with hepatitis B and its clinical application

Prediction of HBV-DNA level by co-detection of serum PreS1 and HBeAg in chronic HBV-carriers

Neccesity of detecting Pre-S1 antigen in asymptomatic carriers of public practitioners

Significance of Serum Pres1-Ag and HBc-IgM in Patients with Acute and Chronic Hepatitis B

Determinations of PreS1 antigen in patients with hepatitis B and its clinical significance in tumorigenesis in primary hepatic cancer

Clinical Significance of Combined Detection of HBV DNA,PreS1 and ALT in Patients with Hepatitis B

Serum Levels of Pres Antigen (hbpresag) in Chronic Hepatitis B Virus Infected Patients

Serological Analysis of Large Protein in Sera of HBeAb-positive Patients with Hepatitis B

Correlation Between the Prevalence of Serum HBV DNA and Immunoserologic HBV Markers in the Subjects with or Without Hepatitis.

Significance and Detection of PreS1 Envelope Antigen of Hepatitis B Virus (HBV)

Analysis for Reason of Negative HBeAg Result in HBV DNA-positive Patients

Serum HBeAg and HBV DNA Levels Are Not Always Proportional and Only High Levels of HBeAg Most Likely Correlate with High Levels of HBV DNA: A Community-Based Study.